FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

492611000001103: Ovranette tablets (Wyeth Laboratories) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17106701000001112 Ovranette tablets (Wyeth Laboratories) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
59569501000001115 Ovranette 150microgram/30microgram tablets (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ovranette tablets (Wyeth Laboratories) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Is a Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Has active ingredient Levonorgestrel false Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Has active ingredient Estradiol false Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Is a Ovranette true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Has specific active ingredient Levonorgestrel true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ovranette tablets (Wyeth Laboratories) 63 tablet 3 x 21 tablets Is pack of False Ovranette tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier
Ovranette tablets (Wyeth Laboratories) 63 tablet 3 x 21 tablets Has AMP True Ovranette tablets (Wyeth Laboratories) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start